JT Stratford LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,427
Closed -$1.05M 276
2024
Q1
$1.05M Buy
9,427
+599
+7% +$64.6K 0.21% 129
2023
Q4
$890K Sell
8,828
-8,732
-50% -$866K 0.2% 122
2023
Q3
$1.52M Sell
17,560
-1,081
-6% -$97.7K 0.39% 64
2023
Q2
$1.76M Sell
18,641
-7,100
-28% -$600K 0.47% 56
2023
Q1
$1.94M Buy
25,741
+14,607
+131% +$1.1M 0.56% 44
2022
Q4
$856K Buy
+11,134
New +$846K 0.27% 100
2021
Q3
Sell
-18,690
Closed -$1.07M 214
2021
Q2
$1.07M Buy
18,690
+441
+2% +$25.8K 0.34% 83
2021
Q1
$1.11M Buy
18,249
+53
+0.3% +$2.92K 0.39% 65
2020
Q4
$975K Buy
18,196
+797
+5% +$41.4K 0.37% 70
2020
Q3
$817K Sell
17,399
-566
-3% -$29K 0.35% 70
2020
Q2
$938K Sell
17,965
-5,288
-23% -$273K 0.48% 65
2020
Q1
$1.11M Buy
23,253
+132
+0.6% +$6.85K 0.68% 49
2019
Q4
$1.17M Buy
+23,121
New +$1.19M 0.54% 56

Other funds holding CAH

JT Stratford LLC's CAH Position: Q2 2024 in Review

JT Stratford LLC sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 9,427 shares — an estimated $1.05M sold.

JT Stratford LLC first reported a position in CAH in Q4 2019 and held it in 13 quarters. The position peaked at $1.94M in Q1 2023. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • JT Stratford LLC reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • JT Stratford LLC sold 9,427 Cardinal Health shares in Q2 2024, an estimated $1.05M.
  • JT Stratford LLC first reported a position in Cardinal Health in Q4 2019 and held it in 13 quarters.
  • JT Stratford LLC's Cardinal Health position peaked at $1.94M in Q1 2023.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on JT Stratford LLC's 13F filing for Q2 2024, filed 14 Aug 2024.